COMMUNIQUÉS West-GlobeNewswire

Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019
01/03/2019
RALEIGH, N.C., March 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation [...]
Microbot Medical Maintains 2019 Milestone Targets Following Recent Court Decision
01/03/2019
HINGHAM, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) is maintaining its milestone targets for 2019 following the recently announced decision of the New York State Supreme Court to [...]
Akorn Comments on Favorable Court Order
01/03/2019
LAKE FOREST, Ill., March 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) announced today that the Delaware Court of Chancery has denied a request by Fresenius Kabi AG to bring a fraud claim against Akorn. On [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/03/2019
EMERYVILLE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has issued inducement awards to five new [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/03/2019
BURLINGTON, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to five new employees for an aggregate of 19,250 shares of common stock [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/03/2019
BOSTON, March 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/03/2019
CHICAGO, March 01, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2018 Financial Results and Business Updates
01/03/2019
CAMBRIDGE, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Tonix Pharmaceuticals Announces Share Repurchase Program
01/03/2019
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that its Board of Directors has approved a share repurchase program pursuant to [...]
ICU Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference
01/03/2019
SAN CLEMENTE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
Logan Boulet’s Parents, Toby & Bernadine Boulet, to Launch GREEN SHIRT DAY In Honour of “Logan Boulet Effect” and Organ Donation Awareness
01/03/2019
LETHBRIDGE, Alberta, March 01, 2019 (GLOBE NEWSWIRE) -- Toby and Bernadine Boulet will be hosting a Press Conference at Lethbridge City Hall, Lethbridge, AB to launch the inaugural Green Shirt Day , in memoriam and in [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
01/03/2019
Company Announcement Copenhagen, Denmark; March 1, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 6,397 restricted stock units and 19,982 warrants to [...]
Major shareholder notification – Marathon Asset Management LLP
01/03/2019
GN Store Nord has received information that Marathon Asset Management LLP has decreased its holdings of GN shares from 5.0% to 4.97%. Marathon Asset Management LLP thereby holds less than 5% of the share capital and the [...]
MRI Interventions to Host Meetings at Roth Capital Conference on March 18
01/03/2019
IRVINE, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain stimulation, ablation, [...]
Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019
01/03/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 1 MARCH 2019 at 19.10 EET Orion Corporation: Transfer of 47,279 own B shares on 1 March 2019 In accordance with a decision by the Board of Directors, Orion Corporation has on 1 [...]
Cronos Group Inc. to Hold Full Year and Fourth Quarter 2018 Earnings Conference Call
01/03/2019
TORONTO, March 01, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results and hold its Full Year and Fourth Quarter 2018 Earnings [...]
Information on total number of voting rights and shares composing the share capital as at February 28th, 2019
01/03/2019
Paris, March 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 28 février 2019
01/03/2019
Paris, le 1 er mars 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de [...]
Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting
01/03/2019
Rapid and significant reduction in skin lesions, 66% (p<0.001) and 76% (p<0.001) mean reduction in EASI score in 4 and 7 weeks, respectively. Rapid and significant resolution of worst itch and pain, 57% (p<0. [...]

Pages